Purpose of this Study
We are doing this study to find out if adding azithromycin to the routine single antibiotic preventative therapy can lower the risk of developing infections after a cesarean delivery.
Who Can Participate?
Eligibility
Adults ages 18+ who are pregnant and will be having a scheduled cesarean delivery at Duke University Hospital.
For more information, contact the study team at <a href= "mailto: jennifer.ferrara@duke.edu">jennifer.ferrara@duke.edu.</a>
For more information, contact the study team at <a href= "mailto: jennifer.ferrara@duke.edu">jennifer.ferrara@duke.edu.</a>
Age Range
18-110
Sex/Genders
Female (cisgender)
Non-binary or gender fluid
Looking for Healthy Participants
No
What is Involved?
If you choose to join this study, you will get a random assignment (like a coin flip) to receive either azithromycin or placebo (normal saline) through your existing intravenous (IV) line that is placed before you have your baby. Study participation starts when you come to the hospital to deliver your baby and will end approximately 6 weeks after delivery.
Locations
Duke University Hospital
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
Azithromycin Prophylaxis for Prelabor Cesarean Delivery Trial
Principal Investigator
Brenna
Hughes
Protocol Number
PRO00115734
Phase
III
Enrollment Status
Pending Open to Enrollment